Přejít k obsahu
Merck

Allosteric Inhibition of the Epidermal Growth Factor Receptor.

Biochemistry (2021-02-10)
Julie K L Sinclair, Wesley E Robertson, Deepto Mozumdar, Kim Quach, Alanna Schepartz
ANOTACE

We previously reported a family of hydrocarbon-stapled peptides designed to interact with the epidermal growth factor receptor (EGFR) juxtamembrane (JM) segment, blocking its ability to form a coiled coil dimer that is essential for receptor activation. These hydrocarbon-stapled peptides, most notably E1S, decreased the proliferation of cell lines that express wild-type EGFR (H2030 and A431) as well as those expressing the oncogenic mutants EGFR L858R (H3255) and L858R/T790M (H1975). Although our previous investigations provided evidence that E1S interacted with EGFR directly, the location and details of these interactions were not established. Here we apply biochemical and cross-linking mass spectrometry tools to better define the interactions between E1S and EGFR. Taken with previously reported structure-activity relationships, our results support a model in which E1S interacts simultaneously with both the JM and the C-lobe of the activator kinase, effectively displacing the JM of the receiver kinase. Our results also reveal potential interactions between E1S and the N-terminal region of the C-terminal tail. We propose a model in which E1S inhibits EGFR by both mimicking and inhibiting JM coiled coil formation. This model could be used to design novel, allosteric (and perhaps nonpeptidic) EGFR inhibitors.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Sigma-Aldrich
EGFR Active human, recombinant, expressed in baculovirus infected insect cells, ≥70% (SDS-PAGE)